Cosmo Bio Company,Limited (TYO:3386)
Japan · Delayed Price · Currency is JPY 1,225.00
+6.00 (0.49%)
Jun 4, 2026, 3:30 PM JST
Cosmo Bio Company,Limited Ratios and Metrics
Market cap in millions JPY. Fiscal year is January - December.
Millions JPY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Jun '26 Jun 3, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 6,949 | 7,400 | 6,236 | 5,736 | 5,878 | 6,730 | |
Market Cap Growth | 5.20% | 18.67% | 8.71% | -2.42% | -12.66% | -7.40% |
Enterprise Value | 4,317 | 4,818 | 3,802 | 2,693 | 3,103 | 3,728 |
Last Close Price | 1225.00 | 1304.00 | 1038.93 | 901.90 | 898.83 | 997.49 |
PE Ratio | 20.04 | 21.96 | 23.80 | 12.98 | 11.37 | 9.13 |
PS Ratio | 0.63 | 0.69 | 0.62 | 0.61 | 0.62 | 0.73 |
PB Ratio | 0.69 | 0.74 | 0.65 | 0.64 | 0.68 | 0.81 |
P/TBV Ratio | 0.75 | 0.80 | 0.71 | 0.69 | 0.75 | 0.89 |
P/FCF Ratio | - | 20.22 | 249.44 | 8.57 | 25.67 | 10.91 |
P/OCF Ratio | - | 12.44 | 25.88 | 7.79 | 20.70 | 10.39 |
EV/Sales Ratio | 0.39 | 0.45 | 0.38 | 0.29 | 0.33 | 0.40 |
EV/EBITDA Ratio | 8.37 | 9.45 | 8.36 | 4.03 | 3.24 | 3.07 |
EV/EBIT Ratio | 12.66 | 14.05 | 11.92 | 5.17 | 3.80 | 3.55 |
EV/FCF Ratio | - | 13.17 | 152.08 | 4.03 | 13.55 | 6.04 |
Debt / Equity Ratio | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Debt / EBITDA Ratio | 0.04 | 0.04 | 0.04 | 0.03 | 0.02 | 0.02 |
Debt / FCF Ratio | - | 0.06 | 0.80 | 0.03 | 0.09 | 0.03 |
Net Debt / Equity Ratio | -0.32 | -0.29 | -0.28 | -0.33 | -0.35 | -0.42 |
Net Debt / EBITDA Ratio | -6.25 | -5.74 | -5.87 | -4.49 | -3.15 | -2.91 |
Net Debt / FCF Ratio | - | -7.99 | -106.92 | -4.49 | -13.17 | -5.73 |
Asset Turnover | 0.92 | 0.88 | 0.89 | 0.88 | 0.94 | 0.94 |
Inventory Turnover | 7.33 | 6.53 | 6.38 | 5.61 | 6.12 | 7.54 |
Quick Ratio | 5.43 | 4.24 | 4.88 | 5.23 | 5.62 | 5.73 |
Current Ratio | 6.43 | 5.23 | 6.20 | 6.32 | 6.88 | 6.69 |
Return on Equity (ROE) | 3.58% | 3.42% | 2.90% | 5.23% | 6.52% | 9.49% |
Return on Assets (ROA) | 1.77% | 1.76% | 1.76% | 3.07% | 5.01% | 6.66% |
Return on Invested Capital (ROIC) | 3.30% | 3.27% | 3.62% | 6.34% | 11.00% | 15.62% |
Return on Capital Employed (ROCE) | 3.00% | 3.10% | 3.00% | 5.30% | 8.80% | 11.70% |
Earnings Yield | 4.99% | 4.55% | 4.20% | 7.70% | 8.79% | 10.95% |
FCF Yield | - | 4.95% | 0.40% | 11.66% | 3.90% | 9.17% |
Dividend Yield | 4.10% | 3.83% | 4.81% | 3.33% | 4.00% | 3.61% |
Payout Ratio | - | 103.26% | 66.79% | 44.57% | 44.87% | 30.26% |
Buyback Yield / Dilution | 1.85% | 2.21% | 0.22% | -0.40% | 0.06% | 2.01% |
Total Shareholder Return | 6.00% | 6.05% | 5.03% | 2.93% | 4.06% | 5.62% |